Reducing the risk of type 2 diabetes following gestational diabetes

  • Research type

    Research Study

  • Full title

    Reducing the risk of Type 2 diabetes after gestational diabetes: Exploring women's views on health behaviour change interventions incorporating mobile technology.

  • IRAS ID

    192921

  • Contact name

    Brian RW McMillan

  • Contact email

    b.mcmillan@sheffield.ac.uk

  • Sponsor organisation

    Sheffield Teaching Hospitals NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    STH19316, Sheffield Teaching Hospitals Project Number

  • Duration of Study in the UK

    1 years, 0 months, 1 days

  • Research summary

    RESEARCH QUESTION
    How can we reduce the risk of women diagnosed with Gestational Diabetes (GD) going on to develop Type 2 Diabetes Mellitus (T2DM)?
    BACKGROUND
    Gestational diabetes is a condition affecting around 1 in 20 pregnant women. It interferes with the body’s ability to convert the sugars in food into energy, leading to an increase in blood sugar levels. It usually resolves after pregnancy, but women diagnosed with GD are over seven times more likely to develop T2DM, which has many negative health consequences including an average reduced life expectancy of 10 years.
    Maintaining a healthy weight, regular exercise, and a healthy diet can help reduce the risk of women who have had GD going on to develop T2DM. This study would help inform a health behaviour change intervention aimed at supporting women diagnosed with GD to engage in behaviours that would reduce their risk of T2DM. The study would help identify the barriers and facilitators (things that would make it easier) to engaging in these health behaviours. It would also investigate how mobile health technologies (mHealth) could be used to help reduce the risk of progression from GD to T2DM.
    WHO, WHERE AND HOW?
    We plan to conduct interviews with 20-25 women who have been diagnosed with GD in last 6 months. Women would be identified as being eligible through the routine screening they receive as part of their antenatal care at Jessop Wing Hospital in Sheffield. They would be invited to take part when sent a letter reminding them to attend for a post natal blood test. The interviews would be conducted by a GP trainee and last between 30-45 minutes. The interviews would be conducted wherever was most convenient for the woman. The interviews would be audio recorded and transcribed, but those taking part would remain anonymous.

  • REC name

    Wales REC 7

  • REC reference

    16/WA/0084

  • Date of REC Opinion

    14 Mar 2016

  • REC opinion

    Favourable Opinion